Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

Lung cancer is the leading cause of cancer-related deaths worldwide, often diagnosed at advanced stages when treatment options are limited. The two most common types of lung cancer are non-small cell ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas. The first patient was dosed in the SKYBRIDGE ...

BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon ...

A team of researchers from the Department of Biological Sciences and Bioengineering at the Indian Institute of Technology, Kanpur, have successfully visualised the atomic structure of CXCR2, a key ...

Kanpur have successfully visualised the atomic structure of CXCR2, a key human receptor associated with cancer progression and respiratory disorders. Their findings, published in Molecular Cell ...

Pinar Uysal-Onganer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Dec. 19, 2024 – The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC). Sold under the brand name ...

“Although lung cancer overall is decreasing because of declines in tobacco use, lung cancer among people who have never smoked has been rising significantly,” Wojcicki wrote in a YouTube blog ...

Ultrasensitive In2O3-Based Nanoflakes for Lung Cancer Diagnosis and the Sensing Mechanism Investigated by Operando Spectroscopy. ACS Sensors , 2024; DOI: 10.1021/acssensors.4c01298 Cite This Page : ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years. A British ...

I think it just strengthens the case to at least discuss this option with all patients. 0:57 | I think for the last 2 or 3 years, every cancer conference has led to very important results in thoracic ...